NCT03755297View on ClinicalTrials.gov

Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells

NATerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

August 12, 2022

Study Completion Date

November 12, 2022

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Blood sample analysis of patients treated as standard care

Blood sample to analyse percentage of blood cells (regulatory B cells et T cells)

Trial Locations (1)

34

University Hospital of Montpellier, Montpellier

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Centre National de la Recherche Scientifique, France

OTHER

collaborator

Pfizer

INDUSTRY

lead

University Hospital, Montpellier

OTHER

NCT03755297 - Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells | Biotech Hunter | Biotech Hunter